The advisory panel wasn’t convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
Source: US Top News and Analysis
Related Posts
AMD, Oracle, Microsoft and the IGV lead a monster week for tech stocks
Oracle, AMD and Microsoft are on pace for historic weeks, while Intel, Broadcom, Micron, Marvell…
Kering looks to double profits as it unveils ambitious turnaround plan to revive Gucci
The “ReconKering” strategy announced Thursday includes more than doubling its 2025 recurring operating margin of…
Airline CEOs urged by lawmaker to lower fares if fuel prices come down
Airlines have raised airfare, fuel surcharges and baggage fees this year to help cover a…